Page last updated: 2024-09-03

tazobactam and Airflow Obstruction, Chronic

tazobactam has been researched along with Airflow Obstruction, Chronic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chiang, TT; Chiu, CC; Lin, TC; Wu, RX; Yang, YS1
Hameed, S; Johnson, M; Lipman, M; Tariq, S; Tyrer, M1

Other Studies

2 other study(ies) available for tazobactam and Airflow Obstruction, Chronic

ArticleYear
Recurrence of Cytomegalovirus Viremia Causing Gastrointestinal Tract Bleeding at Different Sites in an Immuno-competent Patient.
    The American journal of the medical sciences, 2017, Volume: 353, Issue:6

    Topics: Aged, 80 and over; Anti-Bacterial Agents; Blood Transfusion; Colitis; Colon; Cytomegalovirus; Cytomegalovirus Infections; Diarrhea; Esomeprazole; Gastrointestinal Hemorrhage; Gastrointestinal Tract; Humans; Immunocompetence; Male; Penicillanic Acid; Piperacillin; Pneumonia; Pulmonary Disease, Chronic Obstructive; Steroids; Tazobactam; Treatment Outcome; Viremia

2017
Pseudomonal sepsis with subcutaneous nodules in an HIV-infected individual with high CD4 counts.
    The Journal of infection, 2005, Volume: 51, Issue:5

    Topics: Anti-Bacterial Agents; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4-Positive T-Lymphocytes; Gentamicins; Glucocorticoids; HIV Infections; Humans; Lymphocyte Count; Male; Middle Aged; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Pulmonary Disease, Chronic Obstructive; Respiration, Artificial; Sepsis; Skin Diseases; Tazobactam; Treatment Outcome

2005